• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts

    المصدر: Buzz FX / 20 فبراير 2025 03:31:12   America/Chicago


    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeatFebruary 20, 2025 ShareLink copied to clipboard. Shares of Sarepta Therapeutics, Inc.
    Read more...
شارك على،